NCT02565810View on ClinicalTrials.gov

An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Adalimumab PFS and Pen

Trial Locations (2)

Unknown

Medica Pro Familia Sp. z o.o. S.K.A. Oddzial Gdynia, Gdynia

Medica pro Familia Sp z o.o. S.K.A Oddzial Warszawa, Warsaw

All Listed Sponsors

lead

Samsung Bioepis Co., Ltd.

INDUSTRY

NCT02565810 - An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter